Male Germ Cell Tumor
|
disease |
Neoplasms; Male Urogenital Diseases; Endocrine System Diseases
|
Neoplastic Process
|
4
|
|
0.300 |
None |
|
0 |
|
|
|
Acute Myeloid Leukemia, M1
|
disease |
Neoplasms
|
Neoplastic Process
|
125
|
|
0.300 |
None |
1.000 |
1 |
|
1995 |
1995 |
Acute Myeloid Leukemia (AML-M2)
|
disease |
Neoplasms
|
Neoplastic Process
|
125
|
5
|
0.310 |
None |
1.000 |
1 |
|
1995 |
1999 |
Pregnancy Complications, Cardiovascular
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Cardiovascular Diseases
|
Disease or Syndrome
|
4
|
|
0.300 |
None |
1.000 |
1 |
|
2000 |
2000 |
Acute Lung Injury
|
disease |
Respiratory Tract Diseases
|
Injury or Poisoning
|
22
|
3
|
0.300 |
None |
1.000 |
1 |
|
2000 |
2000 |
Ventricular Dysfunction, Left
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
30
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Myasthenia Gravis
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
6
|
66
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Myasthenia Gravis, Generalized
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Myasthenia Gravis, Ocular
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
6
|
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Alloxan Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
108
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Anemia, Splenic
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Necrosis
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Organ or Tissue Function
|
55
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Hypersplenism
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
|
0.400 |
None |
1.000 |
1 |
|
2005 |
2005 |
Streptozotocin Diabetes
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
108
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Hematological Disease
|
group |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
8
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Myocardial Diseases, Secondary
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
69
|
|
0.300 |
None |
1.000 |
3 |
|
2000 |
2007 |
Cardiomyopathies, Primary
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
69
|
1
|
0.300 |
None |
1.000 |
3 |
|
2000 |
2007 |
Cardiomyopathies
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
130
|
172
|
0.300 |
None |
1.000 |
3 |
|
2000 |
2007 |
Autoimmune Lymphoproliferative Syndrome Type 1, Autosomal Dominant
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
4
|
|
0.300 |
None |
1.000 |
2 |
|
2005 |
2007 |
Cardiomyopathy, Dilated
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
48
|
455
|
0.510 |
None |
1.000 |
1 |
|
1999 |
2007 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
108
|
|
0.500 |
None |
1.000 |
1 |
|
2005 |
2009 |
Lymphoma, Non-Hodgkin
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
32
|
4
|
0.540 |
None |
1.000 |
0 |
2
|
1998 |
2010 |
Malaria, Falciparum
|
disease |
Infections
|
Disease or Syndrome
|
4
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
31
|
2
|
0.410 |
None |
1.000 |
1 |
|
1999 |
2011 |
Splenomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
22
|
19
|
0.400 |
None |
1.000 |
1 |
2
|
2011 |
2011 |